Equities

Resonance Health Ltd

Resonance Health Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.038
  • Today's Change0.00 / 0.00%
  • Shares traded427.25k
  • 1 Year change-25.49%
  • Beta1.1818
Data delayed at least 20 minutes, as of Nov 13 2024 23:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Resonance Health Ltd grew revenues 95.15% from 4.51m to 8.80m while net income improved from a loss of 780.36k to a gain of 169.30k.
Gross margin--
Net profit margin1.92%
Operating margin-7.56%
Return on assets1.08%
Return on equity1.62%
Return on investment1.40%
More ▼

Cash flow in AUDView more

In 2024, Resonance Health Ltd increased its cash reserves by 7.75%, or 493.20k. Cash Flow from Financing totalled 3.01m or 34.18% of revenues. In addition the company generated 1.39m in cash from operations while cash used for investing totalled 3.94m.
Cash flow per share0.0014
Price/Cash flow per share26.17
Book value per share0.0245
Tangible book value per share0.0024
More ▼

Balance sheet in AUDView more

Resonance Health Ltd has a Debt to Total Capital ratio of 25.27%, a higher figure than the previous year's 1.74%.
Current ratio1.51
Quick ratio--
Total debt/total equity0.3381
Total debt/total capital0.2527
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.